Blood Pressure Medicine Recalled Due to Impurity in Two Batches

Due to unsafe nitrosamine levels, Aurobindo Pharma USA is recalling two batches of quinapril and hydrochlorothiazide pills. While nitrosamines are naturally present in water and a variety of foods (meats, dairy products, and vegetables included), the FDA has warned that prolonged exposure to levels above the safe threshold could increase the risk of cancer. This voluntary recall from Aurobindo was posted on their website.

High blood pressure, or hypertension, can be treated with a combination of quinapril and hydrochlorothiazide. The recall affects two batches of Aurobindo 20 mg/12.5 mg with expiry dates until January 2023; the notice lists the affected lot numbers. The pills are pink and spherical, with the letters “D” and”19″ written on opposite sides.

The FDA has issued a warning to anyone who may be in possession of this drug to consult with their doctor before discontinuing use. If your doctor has suggested that you try another medicine for your high blood pressure, you should talk to them about the potential advantages and drawbacks.

Aurobindo claims it hasn’t received any allegations of harm from the recalled product as of yet. For consumers who have medical inquiries regarding the recall, Aurobindo may be reached at 866-850-2876 (option 2) or through email at [email protected] Customers who have concerns or questions about returns should dial 888-504-2014.

Since the beginning of the year, there have been many recalls of blood pressure drugs due to concerns about excessive nitrosamine levels. A rise in testing for contaminants like nitrosamines is likely to blame for the “wave” of recalls, as reported by The New York Times. Although many medicine and cosmetic recalls are issued due to concerns about contamination or impurities, this doesn’t always indicate that the product in question poses an imminent threat to users. Instead, it’s prolonged, heavy usage that raises eyebrows.